Matilde Baltazares-Lipp

Matilde Baltazares-Lipp

Auto-generated profile, based on publicly available information

Matilde Baltazares-Lipp

Experimental Surgery Department, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
CHClaudia Hernández-Jiménez
Claudia Hernández-Jiménez
JOJ. Raul Olmos-Zuniga
J. Raul Olmos-Zuniga
MBMatilde Baltazares-Lipp
Matilde Baltazares-Lipp
RJRogelio Jasso-Victoria
Rogelio Jasso-Victoria
APAdrián Polo-Jerez
Adrián Polo-Jerez
MSMariana Silva-Martínez
Mariana Silva-Martínez
Lung transplantation requires optimization of donor’s organ use through ex vivo lung perfusion (EVLP) to avoid primary graft dysfunction. Biomarkers can aid in organ selection by providing early evidence of suboptimal lungs during EVLP and thus avoid high-risk transplantations. However, predictive biomarkers of pulmonary graft function such as endothelin-converting enzyme (ECE-1) and vascular endothelial growth factor (VEGF) have not been described under EVLP with standard prolonged hypothermic preservation, which are relevant in situations where lung procurement is difficult or far from the transplantation site. Therefore, this study is aimed at quantifying ECE-1 and VEGF, as well as determining their association with hemodynamic, gasometric, and mechanical ventilatory parameters in a swine model of EVLP with standard prolonged hypothermic preservation. Using a protocol with either immediate (I-) or delayed (D-) initiation of EVLP, ECE-1 levels over time were found to remain constant in both study groups ( RM-ANOVA), while the VEGF protein was higher after prolonged preservation, but it decreased throughout EVLP ( RM-ANOVA). Likewise, hemodynamic, gasometric, mechanical ventilatory, and histological parameters had a tendency to better results after 12 hours of hypothermic preservation in the delayed infusion group.

1 June 2022 in Journal of Investigative Surgery
Verified
Journal Article
Closed access
MSMariana Silva-Martínez
Mariana Silva-Martínez
JOJ. Raul Olmos-Zuniga
J. Raul Olmos-Zuniga
JCJazmin Calyeca
Jazmin Calyeca
MBMatilde Baltazares-Lipp
Matilde Baltazares-Lipp
MGMiguel Gaxiola-Gaxiola
Miguel Gaxiola-Gaxiola
JVJuan Carlos Vázquez-Minero
Juan Carlos Vázquez-Minero
Tracheal stenosis (TS) is a complication of prolonged intubation, tracheotomy, and tracheal surgery that compromises the vascular supply. Animal models are essential for studying its pathophysiology and the effect of interventions. To establish a TS model in rats secondary to tracheal autotransplantation with a graft submerged in bleomycin (Atx-Bleo). Additionally, to evaluate the clinical and histological changes, as well as the expression of newly formed collagen (NFC), isoforms of transforming growth factor beta (TGFβ), fibronectin (FN), elastin (ELN), integrin β1 (ITGβ1), and matrix metalloproteinase 1 (MMP1) in TS. Twenty Wistar rats were divided into three groups: group I (n = 20) control; group II (n = 10) end-to-end anastomosis of the trachea (tracheoplasty); and group III (n = 10) Atx-Bleo. The animals were evaluated clinically, tomographically, macroscopically, morphometrically, and microscopically. NFC deposition, and the expression of profibrotic and antifibrotic proteins were evaluated in tracheal scars. All animals survived the surgical procedure and the study period. Compared with the other study groups, the Atx-Bleo group developed TS and fibrosis, exhibited higher expression of NFC, TGFβ1, TGFβ2, FN, ELN, and ITGβ1, and mild expression of TGFβ3 and MMP1 (p < 0.005; analysis of variance, Dunnett and Tukey tests). Atx-Bleo in TS model rats produces tomographic and histological changes, and induces the upregulation of profibrotic proteins (TGFβ1, TGFβ2, collagen, FN, ELN, ITGβ1) and downregulation of antifibrotic proteins (TGFβ3, MMP1). Therefore, this model may be used to test new pharmacological treatments for reversing or preventing TS, and conduct basic studies regarding its pathophysiology.